Assure Neuromonitoring Earns Joint Commission Accreditation
Market Leader Receives Prestigious Surgical Ambulatory Healthcare Accreditation
DENVER, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that it has earned The Joint Commission’s Surgical Ambulatory Health Care Accreditation by demonstrating continuous compliance with its performance standards.
By adding this highly regarded accreditation, the Company further confirms its commitment to providing patients, hospitals, and surgical teams with intraoperative neuromonitoring (IONM) expertise that ensures patient safety for the thousands of complex procedures that Assure supports each year.
“This esteemed accreditation from The Joint Commission is fully aligned with the Company’s mission of providing exceptional patient care,” said John A. Farlinger, Assure’s executive chairman and CEO. “The designation further differentiates Assure from our industry peers given that only a very small percentage of IONM companies have achieved this nationally recognized quality indicator.”
The Surgical Ambulatory Healthcare Accreditation is effective for a three-year period beginning September 18, 2019, and applies to the various services provided by Assure Neuromonitoring, which encompass patient care verticals, recordkeeping, financial administration, internal quality controls and ethical policies. It also applies to the Company’s real-time neuromonitoring professionals, including their communication and collaboration with onsite surgical neurophysiologists, surgeons and Operating Room teams.
“This accreditation demonstrates our unwavering commitment to providing clinical excellence for the surgeons we partner with and enhanced safety for the patients we serve,” said Stephanie Krouse, VP, national technologist manager at Assure. “The recognition is also evidence of our stringent operational standards and unique clinical expertise in intraoperative neuromonitoring.”
Mark Pelletier, RN, MS, chief operating officer, Accreditation and Certification Operations, and chief nursing executive, The Joint Commission, commented: “We commend Assure Neuromonitoring for its continuous quality improvement efforts in patient safety and quality of care.”
About Assure Holdings
Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. While Assure focuses primarily on supporting spinal and vascular surgeries, plans are in place to support other classes of medicine that rely on the standard of care that intraoperative neuromonitoring provides. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission’s Gold Seal of Approval®. For more information, visit the company’s website at www.assureneuromonitoring.com.
About The Joint Commission
Founded in 1951, The Joint Commission seeks to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission accredits and certifies more than 22,000 health care organizations and programs in the United States. An independent, nonprofit organization, The Joint Commission is the nation’s oldest and largest standards-setting and accrediting body in health care. Learn more about The Joint Commission at www.jointcommission.org.
This news release contains certain statements that may constitute forward-looking information and forward-looking statements under applicable securities laws. All statements, other than those of historical fact, which address activities, events, outcomes, results, developments, performance or achievements that Assure anticipates or expects may or will occur in the future (in whole or in part) should be considered forward-looking information and forward-looking statements. Such information or statements may involve, but is not limited to, comments with respect to strategies, expectations, planned operations and future actions of the Company. Often, but not always, forward-looking information or forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or statements formed in the future tense or indicating that certain actions, events or results "may", "could", "would", "might" or "will" (or other variations of the forgoing) be taken, occur, be achieved, or come to pass. Forward-looking information and forward-looking statements are based on currently available competitive, financial and economic data and operating plans, strategies or beliefs as of the date of this news release, but involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of Assure to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information and the forward-looking statements. Such factors may be based on information currently available to Assure, including information obtained from third-party industry analysts and other third-party sources, and are based on management's current expectations or beliefs regarding future growth, results of operations, future capital (including the amount, nature and sources of funding thereof) and expenditures. Readers are cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements in this news release speak only as of the date of this release and Assure undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release. Any and all forward-looking information contained in this press release is expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
Released October 15, 2019